The Complexity of Malignant Glioma Treatment

IOZK Webinar auf dem World Cancer Series

Fachärzte Talk zur kombinierten Immun-Chemotherapie

Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution

Neue IOZK Veröffentlichung zum Thema Liquid Biopsy

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

The Application of Evidence-Based Medicine in Individualized Medicine

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience